Mahurkar v. Arrow International, Inc.

160 F. Supp. 2d 927, 2001 U.S. Dist. LEXIS 11709
CourtDistrict Court, N.D. Illinois
DecidedAugust 9, 2001
Docket98 C 4890, 99 C 5711
StatusPublished
Cited by1 cases

This text of 160 F. Supp. 2d 927 (Mahurkar v. Arrow International, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mahurkar v. Arrow International, Inc., 160 F. Supp. 2d 927, 2001 U.S. Dist. LEXIS 11709 (N.D. Ill. 2001).

Opinion

*930 MEMORANDUM OPINION AND ORDER

MORTON DENLOW, United States Magistrate Judge.

Plaintiffs, Dr. Sakharam D. Mahurkar (“Dr.Mahurkar”), owner of United States Patent No. 4,583,968 and Patent No. 4,895,561 and patent licensee, Sherwood Medical Company d/b/a Kendall/Sherwood-Davis & Geek (“Kendall”) (collectively “Plaintiffs”), bring this patent infringement claim against Defendant Arrow International, Inc. (“Arrow”). A Markman hearing was held July 12, 2001 to construe the disputed claims of the 4,583,968 patent and the 4,895,561 patent. A detailed analysis of the Court’s construction of the claims is set forth below.

I. BACKGROUND

A. TECHNICAL BACKGROUND

The patents-in-suit and the accused Arrow products all involve double-lumen catheters for use in hemodialysis. The role of kidneys in the body is to remove toxins from blood. When kidneys fail to function properly due to disease or injury, blood must be cleaned externally. In he-modialysis, blood is removed from a patient, diverted to a blood treatment unit where it is cleansed, and then returned to the patient. Hemodialysis catheters are devices that are inserted into a patient’s vein for removal and return of blood. A double lumen hemodialysis catheter has two separate lumens, or channels, one for removing and one for returning blood. In re Mahurkar, 831 F.Supp. 1354 (N.D.Ill.1993) (Easterbrook, J. sitting by designation).

A typical hemodialysis blood treatment system includes a blood treatment unit for cleansing the blood, a catheter inserted into a patient’s vein for removal of the uncleansed blood and return of cleansed blood, and various connectors and extension tubes that connect the catheter to the blood treatment unit. Patients with diseased or damaged kidneys generally return to a hospital or clinic for regular hemodialysis.

There are over 25,000 U.S. patents that contain the term “catheter” in their specifications and almost 5,000 U.S. patents with this term in their title. The patents-in-suit relate to a certain subset of catheters, double lumen catheters.

B. DR. MAHURKAR, THE INVENTOR

Dr. Mahurkar is a licensed nephrologist who has lived in Chicago for the past 29 years. Until his retirement in 1995, Dr. Mahurkar conducted research and taught nephrology and internal medicine at Cook County Hospital in Chicago. In addition, Dr. Mahurkar has been an inventor, receiving 28 U.S. patents, primarily dealing with catheters and syringes. He has also published a number of academic articles on hemodialysis.

In the 1970s, Dr. Mahurkar designed a catheter divided internally by a septum which created two equal “D” shaped or semi-circular lumens (“double D”) and having a beveled tip. This catheter is the subject of Dr. Mahurkar’s first patent, U.S. Patent No. 4,134,402 (“the ’402 patent”), which expired in 1997 and is not asserted in this suit.

In the early 1980s, Dr. Mahurkar filed a series of patent applications covering variations to his original double D catheter design relating to the catheter tip, and the holes or ports on the catheter. These improvements resulted in two inventions: (1) smooth bore septum-type double lumen catheters; and (2) bent extension catheter assemblies. The patents protecting these two inventions, U.S. Patent No. 4,583,968 (“the ’968 patent”) and U.S. Patent No. 4,895,561 (“the ’561 patent”), are the two patents involved in this litigation.

*931 C. THE ’968 PATENT — SMOOTH BORE SEPTUM TYPE DOUBLE LUMEN CATHETERS

The ’968 patent, 1 entitled “Smooth Bore Double Lumen Catheter,” was issued to Dr. Mahurkar on April 22, 1986. The ’968 patent is a catheter which is made of a cylindrical tube divided into two separate lumens. One lumen is used for removing unclean blood, and the other for returning cleansed blood. The exterior of the cylindrical tube is a smooth bore, and the tip of the tube is conical, making the catheter easy to insert.

D. PRIOR LITIGATION BETWEEN THE PARTIES

The present suit is not the first litigation between Dr. Mahurkar and Arrow concerning the ’968 patent. In 1991, Dr. Mahurkar sued Arrow for infringement of the ’968 patent. On July 22, 1992, the parties entered into an agreed order which terminated the case. Pursuant to the order, Arrow agreed to stop selling catheters having double D designs.

In July 1998, Dr. Mahurkar filed a motion for contempt, in which Kendall intervened, alleging that Arrow’s post-agreed order catheters violated the agreed order and infringed claim 19 of the ’968 patent. Judge Andersen denied Dr. Mahurkar’s motion holding that the issues raised should be the subject of a new lawsuit. This action follows that decision.

E. OTHER LITIGATION INVOLVING THE ’968 PATENT

In 1990, Dr. Mahurkar and Quinton Instrument Company (“Quinton”), Dr. Mahurkar’s then licensee, filed a lawsuit against IMPRA, Inc., a non-party to the pending litigation, alleging infringement of the ’968 patent. The case went to trial against defendant IMPRA before Judge Easterbrook in the Northern District of Illinois. In re Mahurkar, 831 F.Supp. 1364 (N.D.Ill.1993), aff'd, 71 F.3d 1573 (Fed.Cir.1996).

Claims 1 and 19 of the ’968 patent were at issue in the case. Judge Easterbrook found IMPRA infringed on Mahurkar’s patent. Id. Judge Easterbrook’s reasoning and conclusions are extremely useful for the Court in construing the claims presented in this case. The Court will address relevant portions of Judge Easter-brook’s opinion.

F. THE ’561 PATENT — BENT EXTENSION CATHETER ASSEMBLIES

The ’561 patent, 2 entitled “Dual-Lumen Catheter-Connecting System,” was issued to Dr. Mahurkar on January 23, 1990. The ’561 patent concerns the portion of the catheter assembly that connects the catheter tube to the blood treatment unit. This invention improves patient comfort for certain types of catheter placements, and reduces the likelihood the catheters will pull out of the vein during or between hemo-dialysis treatments.

The present litigation involves two separate patent infringement suits that have been consolidated for discovery. The first suit, 98 C 4890, alleges infringement of the ’561 patent, and the second suit, 99 C 5711, alleges infringement of the ’968 patent. The parties have consented to this Court conducting the Markman hearing.

The Court will first explain the rules of claim construction and will then apply those rules to the disputed claims in the ’968 patent and the ’561 patent.

*932 II. RULES OF CLAIM CONSTRUCTION

An infringement analysis involves two steps. The first step is determining the meaning and scope of the patent claims allegedly infringed, also known as claim construction or interpretation. Markman v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
160 F. Supp. 2d 927, 2001 U.S. Dist. LEXIS 11709, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mahurkar-v-arrow-international-inc-ilnd-2001.